Trellis Bioscience Secures $9 Million for Advanced Development of Calpurbatug in Fight Against Joint Infections#United_States#Redwood_City#Drug_Development#Trellis_Bioscience#Calpurbatug
Trellis Bioscience Secures $9 Million for Advanced Development of Calpurbatug in Fight Against Joint Infections
Trellis Bioscience announces $9 million funding for clinical development of Calpurbatug, targeting chronic joint infections. Learn more.
third-news.com
July 16, 2026 at 9:36 PM
Trellis Bioscience Secures $9 Million for Advanced Development of Calpurbatug in Fight Against Joint Infections#United_States#Redwood_City#Drug_Development#Trellis_Bioscience#Calpurbatug